RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Occupational Diseases
Accession: DOID:9005463
browse the term
Definition: Diseases caused by factors involved in one's employment.
Synonyms: exact_synonym: Occupational Disease; Occupational Illnesse; Occupational Illnesses
primary_id: MESH:D009784
subset: RGD_JBrowse_slim
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23791970
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Brcc3
BRCA1/BRCA2-containing complex subunit 3
ISO
RGD
PMID:24973494
RGD:9586067
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16737584
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16737584
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16889696
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15576619
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9230185 PMID:15576619 PMID:15727169 PMID:17178637
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Piga
phosphatidylinositol glycan anchor biosynthesis, class A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37271276
NCBI chr X:30,043,033...30,055,861
Ensembl chr X:30,042,343...30,055,804
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22800774
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24142982
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timp2
TIMP metallopeptidase inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24142982
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Xrcc1
X-ray repair cross complementing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15612468
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Aanat
aralkylamine N-acetyltransferase
ISO
DNA:missense mutation:cds:p.A129T(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12736803 PMID:12736803
RGD:1300232
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
G
Bhlhe40
basic helix-loop-helix family, member e40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25395965
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Cry1
cryptochrome circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
G
Nfil3
nuclear factor, interleukin 3 regulated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25395965
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Per2
period circadian regulator 2
ISO
familial advanced sleep-phase syndrome, OMIM:604348, DNA:point mutation:exon:S662G
RGD
PMID:11232563
RGD:1600411
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
ISO
DNA:missense mutations:cds:multiple (human)
RGD
PMID:11306557
RGD:1358557
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
G
Rorc
RAR-related orphan receptor C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25395965
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Csnk1d
casein kinase 1, delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Per2
period circadian regulator 2
ISO ISS
OMIM:604348 CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Advanced sleep phase syndrome 1
OMIM MouseDO CTD ClinVar
PMID:11232563 PMID:25741868
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
G
Csnk1d
casein kinase 1, delta
ISO
ClinVar Annotator: match by term: Advanced sleep phase syndrome 2
OMIM ClinVar
PMID:15800623 PMID:23636092
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Per3
period circadian regulator 3
ISO
ClinVar Annotator: match by term: Advanced sleep phase syndrome 3
ClinVar OMIM
PMID:25741868 PMID:26903630
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
G
Timeless
timeless circadian regulator
ISO
ClinVar Annotator: match by term: Advance sleep phase syndrome, familial, 4
OMIM ClinVar
PMID:25741868
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15982977 PMID:18430447
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Atp1a4
ATPase Na+/K+ transporting subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394417
NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687
G
Flacc1
flagellum associated containing coiled-coil domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394417
NCBI chr 9:60,315,581...60,343,692
Ensembl chr 9:60,315,582...60,343,648
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20005085
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20005085
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20005085
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Rbm26
RNA binding motif protein 26
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394417
NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20005085
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Arg1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26699812
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Atf6
activating transcription factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25324550
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Cfd
complement factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22832039
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Clca1
chloride channel accessory 1
ISO
mRNA, protein:increased expression:lung
RGD
PMID:17637221
RGD:4145655
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
mRNA:decreased expression:leukocyte
RGD
PMID:20514434
RGD:4892076
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Ddit3
DNA-damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25324550
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ephx1
epoxide hydrolase 1
susceptibility
ISO
DNA:SNP:exon:p.Y113H (rs1051740) (human)
RGD
PMID:17159790
RGD:4889408
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:9055949
RGD:5490588
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17563610
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Hspa5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25324550
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8473757
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24142982
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nos2
nitric oxide synthase 2
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:lung
CTD RGD
PMID:12160931 PMID:12160931 PMID:12051993
RGD:4891441 , RGD:4891438
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22537621
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22537621
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Serpina1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12368052
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16221779 PMID:21514415
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tnc
tenascin C
ISO
protein:increased expression:pleura
RGD
PMID:10950882
RGD:4889594
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8473757 PMID:20486865
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tpm4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22537621
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10194187
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Btnl2
butyrophilin-like 2
susceptibility
ISO
DNA:SNP: :rs3117099(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17927685 PMID:17927685
RGD:9685029
NCBI chr20:4,490,169...4,504,002
Ensembl chr20:4,489,517...4,503,341
G
Ccr5
C-C motif chemokine receptor 5
disease_progression
ISO
DNA:polymorphisms:5' utr:multiple (human)
RGD
PMID:20075058
RGD:4892065
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd28
Cd28 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12952926
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Gclm
glutamate cysteine ligase, modifier subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16766924
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Hmox1
heme oxygenase 1
ISO
protein:increased activity:sputum
RGD
PMID:19453654
RGD:4145349
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8977230
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8428540
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
RT1-Db1
RT1 class II, locus Db1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16272364 PMID:17927685
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8105536 PMID:11551429 PMID:14662898 PMID:15273960 PMID:17927685 PMID:17956852 More...
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Tgfb1
transforming growth factor, beta 1
severity
ISO
DNA:polymorphisms: :-509C>T (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15750822 PMID:17785866 PMID:17785866
RGD:4145294
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8428540 PMID:12449171 PMID:15127972 PMID:16980557
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Muc1
mucin 1, cell surface associated
ISO
protein:increased expression:serum
RGD
PMID:15881280
RGD:5131172
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Aanat
aralkylamine N-acetyltransferase
ISO
ClinVar Annotator: match by term: Delayed sleep phase syndrome, susceptibility to
ClinVar
PMID:12736803
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
G
Cry1
cryptochrome circadian regulator 1
susceptibility
ISO
ClinVar Annotator: match by term: Delayed sleep phase syndrome, susceptibility to
OMIM ClinVar
PMID:25741868 PMID:28388406 PMID:32538895
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
G
Il12b
interleukin 12B
ISO
RGD
PMID:12084045
RGD:4145430
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Tnf
tumor necrosis factor
ISO
protein:increased secretion:macrophage DNA:polymorphism:promoter
RGD
PMID:8466130 PMID:11179110
RGD:4143375 , RGD:4143374
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ager
advanced glycosylation end product-specific receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33075463
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Cdh17
cadherin 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
G
Herc2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 1:106,904,789...107,110,997
Ensembl chr 1:106,880,084...107,108,134
G
Pla2g4a
phospholipase A2 group 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Prkca
protein kinase C, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkd1
protein kinase D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
RT1-A2
RT1 class Ia, locus A2
susceptibility
ISO
DNA:SNP: :rs1573294(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr20:4,870,939...4,910,183
G
RT1-B
RT1 class II, locus B
susceptibility
ISO
DNA:SNP: : rs928976(human)
RGD
PMID:24709764
RGD:13506912
G
RT1-DOa
RT1 class II, locus DOa
treatment
ISO
DNA:SNP: :rs3128935(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
susceptibility
ISO
DNA:SNP: : rs928976(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
RT1-S3
RT1 class Ib, locus S3
susceptibility
ISO
DNA:SNP: :rs1573294(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr20:2,670,654...2,675,411
Ensembl chr20:2,670,709...2,675,411
G
Tenm3
teneurin transmembrane protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr16:41,251,909...43,978,594
Ensembl chr16:41,252,182...43,978,594
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16758956
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Foxp3
forkhead box P3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29477354
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29477354
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
RGD
PMID:19254288
RGD:8549579
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Nat1
N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphisms:: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19834256 PMID:19834256
RGD:8552685
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms:: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19834256 PMID:19834256
RGD:8552685
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
RT1-DMa
RT1 class II, locus DMa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16737583
NCBI chr20:4,707,028...4,710,432
Ensembl chr20:4,707,028...4,710,432
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10373407
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Acan
aggrecan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Alg11
ALG11, alpha-1,2-mannosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr16:69,940,540...69,951,617
Ensembl chr16:69,944,349...69,951,601
G
Arhgap22
Rho GTPase activating protein 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548
G
Asah1
N-acylsphingosine amidohydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Atr
ATR serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Car1
carbonic anhydrase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
G
Car3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Cat
catalase
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19273541
RGD:5130756
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccdc180
coiled-coil domain containing 180
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
G
Cdh23
cadherin-related 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419
G
Enoph1
enolase-phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr14:9,531,336...9,557,797
Ensembl chr14:9,531,339...9,569,273
G
Ephb4
EPH receptor B4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr12:19,326,411...19,351,667
Ensembl chr12:19,326,427...19,351,314
G
Fcho1
FCH and mu domain containing endocytic adaptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr16:18,413,452...18,430,795
Ensembl chr16:18,413,363...18,435,104
G
H3f4
H3.4 histone, cluster member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr10:43,740,702...43,741,262
G
Hs3st6
heparan sulfate-glucosamine 3-sulfotransferase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr10:13,781,999...13,788,133
Ensembl chr10:13,781,993...13,788,133
G
Il27ra
interleukin 27 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21857939
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Lrrc29
leucine rich repeat containing 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr19:33,181,713...33,203,583
Ensembl chr19:33,188,352...33,203,545
G
Mdm4
MDM4 regulator of p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr13:44,432,596...44,516,165
Ensembl chr13:44,406,213...44,474,226
G
Nup35
nucleoporin 35
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr 3:65,555,203...65,594,488
Ensembl chr 3:65,558,968...65,585,130
G
Prxl2b
peroxiredoxin like 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr 5:165,462,610...165,465,213
G
Psmb9
proteasome 20S subunit beta 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DQB1*06, HLA-DQB1*08, HLA-DQB1*09 (human)
RGD
PMID:16188098
RGD:7421557
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Spns1
SPNS lysolipid transporter 1, lysophospholipid
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr 1:180,942,088...180,949,415
Ensembl chr 1:180,942,088...180,949,370
G
Tap1
transporter 1, ATP binding cassette subfamily B member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tap2
transporter 2, ATP binding cassette subfamily B member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506645
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Ticam1
TIR domain containing adaptor molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
G
Tmprss3
transmembrane serine protease 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25445010
NCBI chr20:9,254,102...9,273,808
Ensembl chr20:9,254,109...9,274,363
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22273745
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Arg1
arginase 1
IEP ISO
mRNA:increased expression:lung (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15292275 PMID:17365572
RGD:4143368
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Arpc2
actin related protein 2/3 complex, subunit 2
IEP
mRNA:altered expression:lung (rat)
RGD
PMID:18685790
RGD:4893904
NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471
G
C3
complement C3
ISO
DNA:polymorphism (human)
RGD
PMID:12096683
RGD:5129516
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cav1
caveolin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36053221
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26163174
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl7
C-C motif chemokine ligand 7
IEP
RGD
PMID:21830856
RGD:6483764
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Cd36
CD36 molecule
treatment
IMP
RGD
PMID:24053919
RGD:11041147
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Chia
chitinase, acidic
IEP
mRNA:increased expression:lung (rat)
RGD
PMID:18685790
RGD:4893904
NCBI chr 2:193,614,374...193,656,532
Ensembl chr 2:193,614,114...193,656,533
G
Cpm
carboxypeptidase M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24986923
NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220
G
Csf2
colony stimulating factor 2
IEP
protein:increased expression:serum:
RGD
PMID:21505002
RGD:10450467
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:16831302
RGD:4891515
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Egr1
early growth response 1
IEP
protein:increased expression:lung, epithelial cell, macrophage (rat)
RGD
PMID:15033019
RGD:5131937
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eln
elastin
IEP
protein:increased expression:lung connective tissue:
RGD
PMID:7573374
RGD:9585691
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37979906
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
Hmox1
heme oxygenase 1
ISO
protein:increased expression:serum, lung
RGD
PMID:16858012
RGD:4145384
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
IEP
protein:increased expression:lung
RGD
PMID:19534998
RGD:10059658
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
G
Ift88
intraflagellar transport 88
IEP
protein:decreased expression:lung
RGD
PMID:32042332
RGD:155791682
NCBI chr15:31,573,325...31,666,068
Ensembl chr15:31,573,376...31,672,147
G
Il17a
interleukin 17A
ISO
mRNA, protein:increased expression:lung
RGD
PMID:20421647
RGD:4888525
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23640035
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
susceptibility treatment
ISO IDA
DNA:SNP (human)
RGD
PMID:11264025 PMID:23842733
RGD:4142816 , RGD:8551847
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:21072213
RGD:4891500
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27621875
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kif3a
kinesin family member 3a
IEP ISO
protein:decreased expression:lung protein:increased expression:respiratory system fluid/secretion:
RGD
PMID:32042332 PMID:32042332
RGD:155791682 , RGD:155791682
NCBI chr10:37,725,930...37,761,183
Ensembl chr10:37,725,970...37,759,191
G
Marco
macrophage receptor with collagenous structure
treatment
IMP
RGD
PMID:30391304
RGD:41412200
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
G
Mmp13
matrix metallopeptidase 13
IEP
mRNA:increased expression:lung, fibroblast
RGD
PMID:9614183
RGD:10043156
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15292275 PMID:15205031
RGD:4891445
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:37399107
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Pdzrn4
PDZ domain containing RING finger 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24986923
NCBI chr 7:123,816,961...123,965,491
Ensembl chr 7:123,816,961...123,965,491
G
Prkcb
protein kinase C, beta
IDA
protein:increased activation:alveolar macrophage
RGD
PMID:14680365
RGD:1625527
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27621875
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphism: :HLA-DQB1*0402(human)
RGD
PMID:11776400
RGD:36049758
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Rtel1
regulator of telomere elongation helicase 1
IEP
mRNA:decreased expression:lung (rat)
RGD
PMID:29230030
RGD:152977761
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
G
Tert
telomerase reverse transcriptase
IEP
mRNA:increased expression:lung (rat)
RGD
PMID:29230030
RGD:152977761
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tnf
tumor necrosis factor
treatment
ISO IEP
DNA:polymorphisms: :
RGD
PMID:11264025 PMID:25199287
RGD:4142816 , RGD:10450591
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
RGD
PMID:11208652
RGD:5131150
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
RGD
PMID:11208652
RGD:5131150
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Sting1
stimulator of interferon response cGAMP interactor 1
severity
ISO
RGD
PMID:31141689
RGD:39128194
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all